MIM
REGN icon

Meixler Investment Management’s Regeneron Pharmaceuticals REGN Stock Holding History

Meixler Investment Management’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-400
Closed -$254K – 116
2025
Q1 		$254K Sell
400
-7
-2% -$4.82K 0.18% 82
2024
Q4 		$290K Sell
407
-9
-2% -$7.55K 0.21% 80
2024
Q3 		$437K Sell
416
-4
-1% -$4.45K 0.32% 57
2024
Q2 		$441K Sell
420
-5
-1% -$4.85K 0.34% 49
2024
Q1 		$409K Sell
425
-1
-0.2% -$951 0.31% 55
2023
Q4 		$374K Sell
426
-27
-6% -$22.2K 0.31% 54
2023
Q3 		$373K Sell
453
-20
-4% -$15.7K 0.33% 53
2023
Q2 		$340K Sell
473
-5
-1% -$3.85K 0.31% 58
2023
Q1 		$393K Sell
478
-26
-5% -$19.6K 0.38% 48
2022
Q4 		$364K Sell
504
-95
-16% -$70.1K 0.36% 52
2022
Q3 		$413K Sell
599
-17
-3% -$10.7K 0.48% 41
2022
Q2 		$364K Buy
616
+39
+7% +$25.4K 0.42% 45
2022
Q1 		$403K Buy
577
+115
+25% +$72.8K 0.39% 52
2021
Q4 		$292K Buy
+462
New +$284K 0.3% 57

Other funds holding REGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Meixler Investment Management's REGN Position: Q2 2025 in Review

Meixler Investment Management sold out of Regeneron Pharmaceuticals (REGN) in Q2 2025, closing a stake of 400 shares — an estimated $254K sold.

Meixler Investment Management first reported a position in REGN in Q4 2021 and held it in 14 quarters. The position peaked at $441K in Q2 2024. 1,203 funds tracked by Wall St. Rank hold REGN as of Q2 2025.

  • Meixler Investment Management reported no remaining Regeneron Pharmaceuticals position as of Q2 2025 after selling out during the quarter.
  • Meixler Investment Management sold 400 Regeneron Pharmaceuticals shares in Q2 2025, an estimated $254K.
  • Meixler Investment Management first reported a position in Regeneron Pharmaceuticals in Q4 2021 and held it in 14 quarters.
  • Meixler Investment Management's Regeneron Pharmaceuticals position peaked at $441K in Q2 2024.
  • 1,203 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2025.

Based on Meixler Investment Management's 13F filing for Q2 2025, filed 5 Aug 2025.